Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Qualified Small Business Stock (QSBS)

Investors can unlock significant tax advantages by understanding how this specialized equity structure shields millions in capital gains from taxation

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

By MarketScale · InvestmentQsbsSmall BusinessTax Benefits
Share

Key takeaways

01

Investors can unlock significant tax advantages by understanding how this specialized equity structure shields millions in capital gains from taxation

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

In this episode of Weaver: The Alternative Edge, hosts Blayne Lowary and Vardeep Mann delve into the intricacies of Qualified Small Business Stock (QSBS). This conversation provides crucial information for investors and fund managers looking to maximize tax benefits through QSBS. Lowary and Mann bring valuable insights into how QSBS can be a significant advantage for non-corporate taxpayers, providing substantial exclusions on capital gains.

Key Points:

  • QSBS can provide substantial tax exclusions, potentially excluding up to $40 million of gain from taxable income.
  • Claiming QSBS benefits requires proper documentation and portfolio company representation.
  • Investors should be aware of pitfalls like warehouse investments and subsequent closes, which may disqualify QSBS eligibility.

Lowary and Mann discuss the key aspects and potential challenges of Qualified Small Business Stock (QSBS). They emphasize the importance of understanding QSBS eligibility criteria, including the need for proper documentation and portfolio company representations. "One of the requirements for stock to be eligible for QSBS is it has to be received upon original issuance," Lowary said.

One of the requirements for stock to be eligible for QSBS is it has to be received upon original issuance.
— Blayne Lowary

Additionally, the discussion covers critical gray areas, such as the impact of convertible notes and SAFEs on QSBS eligibility and the complexities surrounding carried interest. "Convertible notes and SAFEs are a gray area, specifically regarding when the clock starts for the five-year hold period," Mann said.

Convertible notes and SAFEs are a gray area, specifically regarding when the clock starts for the five-year hold period.
— Vardeep Mann

This episode serves as an essential guide for those navigating the QSBS landscape.

Subscribe and listen to future episodes of Weaver: The Alternative Edge, on Apple Podcasts or Spotify.

©2024

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Jessica Davison - Assistant Vice President of Strategy, Learning & Analytics, United Way of Greater Houston

Jessica Davison - Assistant Vice President of Strategy, Learning & Analytics, United Way of Greater Houston

Jessica Davison serves as the Assistant Vice President of Strategy, Learning & Analytics at United Way of Greater Houston. The article focuses on her strategic role and initiatives in analytics within the organization. The context is in the healthcare industry, with insights pertaining to Texas.

  • 01Jessica Davison is the Assistant Vice President of Strategy, Learning & Analytics at United Way of Greater Houston.
  • 02The article discusses strategic roles and analytics initiatives within healthcare.
  • 03The focus is on the healthcare industry in Texas.

Aug 25, 2026

Epic’s MyChart phishing wave is pushing patient-access teams to treat portal identity as a security perimeter

Epic’s MyChart phishing wave is pushing patient-access teams to treat portal identity as a security perimeter

Hospitals are alerting patients about phishing scams involving Epic’s MyChart, as these scams impersonate the patient portal to deceive users. The concern grows as CMS encourages healthcare innovation and interoperability. As a response, healthcare teams are treating portal identity as a vital security frontier.

  • 01Hospitals are experiencing phishing scams that mimic Epic’s MyChart portal.
  • 02The CMS continues to push for industry-led pledges toward healthcare interoperability.
  • 03Patient portal identity is being prioritized as a critical aspect of cybersecurity.

Aug 25, 2026

Adonis’ new CPO and first CRO signals AI RCM vendors are shifting from pilots to platform operating models

Adonis’ new CPO and first CRO signals AI RCM vendors are shifting from pilots to platform operating models

Adonis has appointed a new Chief Product Officer (CPO) and promoted its first Chief Revenue Officer (CRO), following a successful $40 million Series C funding round and a fourfold increase in revenue. This move underscores a shift among AI RCM vendors, like Adonis, from pilot projects to platform-based operating models. This transition is expected to result in more structured product roadmaps and a strong emphasis on value demonstration for health systems.

  • 01Adonis appointed a new CPO and promoted its first CRO.
  • 02The company achieved a $40 million Series C funding and a fourfold revenue increase.
  • 03AI RCM vendors are moving from pilot projects to platform operating models.

Aug 22, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Expert

M
MarketScale

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512